β-Lactam vs Non–β-Lactam Antimicrobial Prophylaxis and Surgical Site Infection
Selina Largiadèr(University of Lucerne), Walter Zingg(University of Zurich), Danielle Vuichard‐Gysin, Matthias Schlegel, Carlo Balmelli, Holly Jackson(University Hospital of Geneva), Stephan Harbarth(University Hospital of Geneva), Aline Wolfensberger(University of Zurich), Delphine Berthod, Nicolas Troillet(Hôpital du Valais), Sarah Tschudin‐Sutter(University of Basel), Andreas F. Widmer(University of Basel), Rami Sommerstein(University of Bern), Niccolò Buetti(University of Geneva), Philipp Jent(University of Bern), Alexander Schweiger(Zug Cantonal Hospital), Laurence Senn(University of Lausanne), Christelle Perdrieu(Hôpital du Valais), Hugo Sax(University of Bern)
Cited by 8
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|Clinical Microbiology and Infection|2021|615
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
|Journal of Critical Care|2020|350
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
|Eurosurveillance|2008|286